<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent work has shown that p53 gene mutations are frequently found in Epstein-Barr virus (EBV)-positive and EBV-negative cases of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> but not in EBV-associated undifferentiated nasopharyngeal <z:mp ids='MP_0002038'>carcinomas</z:mp> (NPCs) </plain></SENT>
<SENT sid="1" pm="."><plain>Similar <z:mp ids='MP_0001799'>viral</z:mp> gene expression patterns are observed in undifferentiated NPCs and in EBV-positive cases of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>), suggesting that the contribution of the virus to the pathogenesis of these <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> may also be similar </plain></SENT>
<SENT sid="2" pm="."><plain>We have analysed 116 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> for EBV association and for immunohistologically detectable overexpression of p53 </plain></SENT>
<SENT sid="3" pm="."><plain>p53 overexpression was detected in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cell population of 37 (32 per cent) of the cases </plain></SENT>
<SENT sid="4" pm="."><plain>Fifteen cases showed p53-specific labelling of more than 40 per cent of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells; in six of these, virtually <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells were stained </plain></SENT>
<SENT sid="5" pm="."><plain>In eight cases, between 5 and 40 per cent of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells were labelled, and in another 14 cases, less than 5 per cent of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells expressed detectable amounts of p53 </plain></SENT>
<SENT sid="6" pm="."><plain>EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> cases were found in <z:hpo ids='HP_0000001'>all</z:hpo> groups with different levels of p53 overexpression as well as amongst p53-negative cases </plain></SENT>
<SENT sid="7" pm="."><plain>While a more detailed analysis of the p53 gene in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> is required, these data show that overexpression of p53 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> is <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> and that there is no simple correlation between <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> and p53 overexpression </plain></SENT>
</text></document>